Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 3
2007 2
2008 4
2009 1
2010 2
2011 2
2012 2
2013 6
2014 5
2015 5
2016 4
2017 7
2018 7
2019 7
2020 10
2021 7
2022 18
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Carbon-ion radiotherapy for urological cancers.
Ishikawa H, Hiroshima Y, Kanematsu N, Inaniwa T, Shirai T, Imai R, Suzuki H, Akakura K, Wakatsuki M, Ichikawa T, Tsuji H. Ishikawa H, et al. Among authors: wakatsuki m. Int J Urol. 2022 Oct;29(10):1109-1119. doi: 10.1111/iju.14950. Epub 2022 Jun 12. Int J Urol. 2022. PMID: 35692124 Free PMC article. Review.
Why not de-intensification for uterine cervical cancer?
Murakami N, Ando K, Murata M, Murata K, Ohno T, Aoshika T, Kato S, Okonogi N, Saito AI, Kim JY, Kumai Y, Yoshioka Y, Sekii S, Tsujino K, Lowanichkiattikul C, Pattaranutaporn P, Kaneyasu Y, Nakagawa T, Watanabe M, Uno T, Umezawa R, Jingu K, Kanemoto A, Wakatsuki M, Shirai K, Igaki H, Itami J. Murakami N, et al. Among authors: wakatsuki m. Gynecol Oncol. 2021 Oct;163(1):105-109. doi: 10.1016/j.ygyno.2021.07.021. Epub 2021 Jul 19. Gynecol Oncol. 2021. PMID: 34294413
A Phase Ib Study of Durvalumab (MEDI4736) in Combination with Carbon-Ion Radiotherapy and Weekly Cisplatin for Patients with Locally Advanced Cervical Cancer (DECISION Study): The Early Safety and Efficacy Results.
Okonogi N, Murata K, Yamada S, Habu Y, Hori M, Kurokawa T, Inaba Y, Fujiwara T, Fujii Y, Hanawa M, Kawasaki Y, Hattori Y, Suzuki K, Tsuyuki K, Wakatsuki M, Koto M, Hasegawa S, Ishikawa H, Hanaoka H, Shozu M, Tsuji H, Usui H. Okonogi N, et al. Among authors: wakatsuki m. Int J Mol Sci. 2023 Jun 23;24(13):10565. doi: 10.3390/ijms241310565. Int J Mol Sci. 2023. PMID: 37445743 Free PMC article. Clinical Trial.
Carbon-ion radiotherapy for inoperable endometrial carcinoma.
Irie D, Okonogi N, Wakatsuki M, Kato S, Ohno T, Karasawa K, Kiyohara H, Kobayashi D, Tsuji H, Nakano T, Kamada T, Shozu M; and The Working Group of the Gynecological Tumor. Irie D, et al. Among authors: wakatsuki m. J Radiat Res. 2018 May 1;59(3):309-315. doi: 10.1093/jrr/rry003. J Radiat Res. 2018. PMID: 29528414 Free PMC article.
Comprehensive analysis of Japanese nationwide cohort data of particle beam therapy for pulmonary, liver and lymph node oligometastases: particle beam therapy versus high-precision X-ray radiotherapy.
Aibe N, Ogino H, Wakatsuki M, Fujikawa K, Teramukai S, Fukumitsu N, Shiba S, Yamamoto N, Nomoto A, Ono T, Oguri M, Yamaguchi H, Numajiri H, Shibuya K, Okazaki S, Miyasaka Y, Okonogi N, Murata K, Tatebe H, Motegi A, Okimoto T, Yoshino T, Mandai M, Katoh N, Tsuji H, Sakurai H. Aibe N, et al. Among authors: wakatsuki m. J Radiat Res. 2023 Jun 16;64(Supplement_1):i69-i83. doi: 10.1093/jrr/rrad004. J Radiat Res. 2023. PMID: 37053162 Free PMC article.
Carbon-ion radiotherapy versus radiofrequency ablation as initial treatment for early-stage hepatocellular carcinoma.
Fujita N, Kanogawa N, Makishima H, Ogasawara S, Maruta S, Iino Y, Shiko Y, Kanzaki H, Koroki K, Kobayashi K, Kiyono S, Nakamura M, Kondo T, Nakamoto S, Chiba T, Wakatsuki M, Itobayashi E, Obu M, Koma Y, Azemoto R, Kawasaki Y, Kato J, Tsuji H, Kato N. Fujita N, et al. Among authors: wakatsuki m. Hepatol Res. 2022 Dec;52(12):1060-1071. doi: 10.1111/hepr.13827. Epub 2022 Sep 3. Hepatol Res. 2022. PMID: 35951438
89 results